NASDAQ · Biotechnology

Rallybio Corporation (RLYB) Stock

$17.02 +0.18% NASDAQ: RLYB Healthcare

Valuation

MetricValue
Price$17.02
Market Cap$90.32M
P/E Ratio2.15
P/B Ratio1.03
P/S Ratio140.31
EPS (TTM)$-1.59
52-Week High$17.57
52-Week Low$3.67
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE68.56%
ROA46.45%
ROCE-25.10%
Gross Margin-2800.00%
Operating Margin-2800.00%
Net Margin-9.11%
Debt/Equity0.00
Current Ratio15.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$1.0M$1.0M
Operating Profit$-46.0M$-68.0M$-79.0M$-60.0M$-28.0M
Net Profit$-47.0M$-67.0M$-75.0M$-58.0M$-9.0M
EPS$-11.68$-16.72$-14.72$-10.64$-1.59
Op Margin———-9512.0%-3270.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$182.0M$180.0M$116.0M$68.0M$62.0M
Total Liabilities$7.0M$11.0M$9.0M$6.0M$4.0M
Cash$175.0M$57.0M$24.0M$14.0M$31.0M
Borrowings$0$1.0M$0$0$0

Latest News

VERAXA Biotech Expands R&D Hub in Heidelberg as Programs Advance Towards Clinical Development Exec Edge · Jun 24, 2026 Prolium Bioscience Sclerosis, Lupus Treatment Studies Advancing Exec Edge · Jun 22, 2026 RLYB Stock Hits 2-Year Highs After Unveiling Merger With Avenzo – How Much Of The New Company Will Rallybio Shareholders Own? Stocktwits · Jun 1, 2026 RallyBio tries again for reverse merger, this time with Avenzo BioPharma Dive · Jun 1, 2026 Rallybio Agrees to Acquire Avenzo Therapeutics MT Newswires · Jun 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-46.0M$-57.0M$-60.0M$-49.0M$-30.0M
Investing Cash Flow$-3.0M$-112.0M$28.0M$33.0M$47.0M
Financing Cash Flow$-3.0M$0$0$0$0
Net Cash Flow$35.0M$-118.0M$-32.0M$-11.0M$17.0M
Free Cash Flow$-46.0M$-57.0M$-60.0M$-49.0M$-30.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.08
FCF Yield29.06%
Quick Ratio27.26
Interest Coverage0.00
Return 1Y387.92%
Return 3Y-62.94%
Return 5Y—

Ownership

Insiders Held4.22%
Institutions Held106.84%
Institutions Float Held111.55%
Institutional HolderSharesReport Date
FMR, LLC793,4512026-03-31
Viking Global Investors, L.P.524,3472026-03-31
Cormorant Asset Management, LP400,0002026-03-31
TPG GP A, LLC378,5512026-03-31
Balyasny Asset Management LP376,5732026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BOLDBoundless Bio, Inc. $2.53 -1.94% -0.92 $56.86M 0.00%
CVKDCadrenal Therapeutics, Inc. $0.91 -2.10% -0.19 $3.25M 0.00%
IBIOiBio, Inc. $0.87 -5.33% -3.46 $56.01M 0.00%
INTSIntensity Therapeutics, Inc. $3.63 -1.36% -0.71 $9.81M 0.00%
ITRMIterum Therapeutics plc $0.03 -10.98% -0.06 $1.60M 0.00%

About Rallybio Corporation

Rallybio Corporation is led by CEO Stephen Uden, employs 15 people, headquartered in US, publicly traded since 2021.

Rallybio Corporation (RLYB) stock trades at $17.02 with a market capitalization of $90.32M. The stock is valued at a price-to-earnings (P/E) ratio of 2.15, price-to-book of 1.03, price-to-sales of 140.31. Over the past 52 weeks the stock has ranged between $3.67 and $17.57, and currently trades 3.2% below its 52-week high.

On profitability, Rallybio Corporation generates a return on equity (ROE) of 68.56% — well above the market average, a sign of a high-quality business, return on capital employed of -25.10%, an operating margin of -2800.00%, a net profit margin of -9.11%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides